AAP News Vol. 3 No. 2 February 1987, p. 13
© 1987 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

 Previous Article  |  Next Article 

`New frontier' of AIDS to be feature topic at CME meeting

The use of gamma globulins is a "new frontier" that is having an impact on the treatment of AIDS, Kawasaki Syndrome and an increasing number of other areas, according to E. Richard Stiehm, M.D., FAAP.

Dr. Stiehm, professor of pediatrics and heard of the Division of Allergy/ Immunology at UCLA School of Medicine, will provide a general overview of AIDS and other immunodeficiencies at the AAP Continuing Medical Education (CME) course "Advances in Dermatology and Immunology." The course is scheduled for April 3-5 in Washington, D.C.